279 related articles for article (PubMed ID: 12604698)
1. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Hemrick-Luecke SK; Evans DC
Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
[TBL] [Abstract][Full Text] [Related]
3. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
Hewitt KN; Lee MD; Dourish CT; Clifton PG
Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
[TBL] [Abstract][Full Text] [Related]
6. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
7. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Dekeyne A; Girardon S; Millan MJ
Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
[TBL] [Abstract][Full Text] [Related]
9. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
Calcagno E; Carli M; Baviera M; Invernizzi RW
J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
[TBL] [Abstract][Full Text] [Related]
10. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.
Van de Kar LD; Javed A; Zhang Y; Serres F; Raap DK; Gray TS
J Neurosci; 2001 May; 21(10):3572-9. PubMed ID: 11331386
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Zaniewska M; McCreary AC; Wydra K; Filip M
Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
Fletcher PJ; Tampakeras M; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2007 Dec; 195(2):223-34. PubMed ID: 17673981
[TBL] [Abstract][Full Text] [Related]
13. Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine.
Higgins GA; Ouagazzal AM; Grottick AJ
Br J Pharmacol; 2001 Jun; 133(4):459-66. PubMed ID: 11399662
[TBL] [Abstract][Full Text] [Related]
14. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
Millan MJ; Dekeyne A; Gobert A
Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
[TBL] [Abstract][Full Text] [Related]
15. Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.
Kennett G; Lightowler S; Trail B; Bright F; Bromidge S
Eur J Pharmacol; 2000 Jan; 387(2):197-204. PubMed ID: 10650160
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Brain Res; 2000 May; 865(1):85-90. PubMed ID: 10814735
[TBL] [Abstract][Full Text] [Related]
17. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
18. Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
Zaniewska M; McCreary AC; Filip M
Synapse; 2009 Aug; 63(8):653-61. PubMed ID: 19347958
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
[TBL] [Abstract][Full Text] [Related]
20. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.
Overstreet DH; Knapp DJ; Moy SS; Breese GR
Psychopharmacology (Berl); 2003 Jun; 167(4):344-52. PubMed ID: 12677355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
